Optimizing hepatitis B virus screening in the United States using a simple demographics‐based model
Nathan S. Ramrakhiani, Vincent L. Chen, Michael Le, Yee Hui Yeo, Scott D. Barnett, Akbar K. Waljee, Ji Zhu, Mindie H. Nguyen – 7 September 2021
With Alcohol as the Fuel, COVID Is the Match: Liver Transplantation for Alcohol‐Associated Liver Disease Is Increasing in the United States
Patricia P. Bloom, Robert J. Fontana – 7 September 2021
More Than Meets the Eye?
Ying Claire Dorsey, Omobonike Oloruntoba, Avani A. Pendse, Lindsay Y. King – 7 September 2021
Magnetic resonance elastography plus Fibrosis‐4 versus FibroScan–aspartate aminotransferase in detection of candidates for pharmacological treatment of NASH‐related fibrosis
Nobuharu Tamaki, Kento Imajo, Suzanne Sharpton, Jinho Jung, Nobuyoshi Kawamura, Masato Yoneda, Mark A. Valasek, Cynthia Behling, Claude B. Sirlin, Atsushi Nakajima, Rohit Loomba – 7 September 2021
A Simple Bacterium Links Heart Infection to Inflammatory Liver Disease
Pierre Isnard, Marion Larue, Aurelia Pitsch, Jean‐Paul Duong Van Huyen, Philippe Seksik, Loic Brot, Sylvain Diamantis, Julie Bruneau, Maxence Rouyer – 7 September 2021
More Than Meets the Eye?
Ying Claire Dorsey, Omobonike Oloruntoba, Avani A. Pendse, Lindsay Y. King – 7 September 2021
Alcohol‐Induced Liver Injury: Down‐regulation and Redistribution of Rab3D Results in Atypical Protein Trafficking
Carol A. Casey, Amanda J. Macke, Ryan R. Gough, Artem N. Pachikov, Mary E. Morris, Paul G. Thomes, Jacy L. Kubik, Melissa S. Holzapfel, Armen Petrosyan – 6 September 2021 – Previous work from our laboratories has identified multiple defects in endocytosis, protein trafficking, and secretion, along with altered Golgi function after alcohol administration.
Ductular reaction promotes intrahepatic angiogenesis through Slit2–Roundabout 1 signaling
Mar Coll, Silvia Ariño, Celia Martínez‐Sánchez, Ester Garcia‐Pras, Javier Gallego, Anna Moles, Beatriz Aguilar‐Bravo, Delia Blaya, Julia Vallverdú, Teresa Rubio‐Tomás, Juan Jose Lozano, Elisa Pose, Isabel Graupera, Andrea Fernández‐Vidal, Albert Pol, Ramón Bataller, Jian‐Guo Geng, Pere Ginès, Mercedes Fernandez, Pau Sancho‐Bru – 6 September 2021
Development of Gastroenterology and Transplant Hepatology Milestones 2.0: A Guide For Programs, Faculty, and Fellows
Brijen J. Shah, Jane E. Onken, Laura Edgar, Janice H. Jou, Keith L. Obstein, Darrell S. Pardi, Seth Richter, Gautham Reddy, Suzanne Rose, Ronald Szyjkowski, Oren K. Fix – 6 September 2021
Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis
Pascale Gluais‐Dagorn, Marc Foretz, Gregory R. Steinberg, Battsetseg Batchuluun, Anna Zawistowska‐Deniziak, Joost M. Lambooij, Bruno Guigas, David Carling, Pierre‐Axel Monternier, David E. Moller, Sebastien Bolze, Sophie Hallakou‐Bozec – 6 September 2021 – No approved therapies are available for nonalcoholic steatohepatitis (NASH). Adenosine monophosphate–activated protein kinase (AMPK) is a central regulator of cell metabolism; its activation has been suggested as a therapeutic approach to NASH.